|
1.
|
Ferenczy A: Laser treatment of genital
human papillomavirus infections in the male patient. Obstet Gynecol
Clin North Am. 18:525–535. 1991.PubMed/NCBI
|
|
2.
|
Kennedy JC, Pottier RH and Pross DC:
Photodynamic therapy with endogenous protoporphyrin IX: basic
principles and present clinical experience. J Photochem Photobiol
B. 6:143–148. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Chen K, Chang BZ, Ju M, Zhang XH and Gu H:
Comparative study of photodynamic therapy vs CO2 laser
vaporization in treatment of condylomata acuminata: a randomized
clinical trial. Br J Dermatol. 156:516–520. 2007.PubMed/NCBI
|
|
4.
|
Herzinger T, Wienecke R, Weisenseel P,
Borelli C, Berking C and Degitz K: Photodynamic therapy of genital
condylomata in men. Clin Exp Dermatol. 31:51–53. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Kacerovska D, Pizinger K, Kumpova M and
Cetkovska P: Genital warts treated by photodynamic therapy.
Skinmed. 6:295–297. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Liang J, Lu XN, Tang H, Zhang Z, Fan J and
Xu JH: Evaluation of photodynamic therapy using topical
aminolevulinic acid hydrochloride in the treatment of condylomata
acuminata: a comparative, randomized clinical trial. Photodermatol
Photoimmunol Photomed. 25:293–297. 2009. View Article : Google Scholar
|
|
7.
|
Wang HW, Wang XL, Zhang LL, Guo MX and
Huang Z: Aminolevulinic acid (ALA)-assisted photodynamic diagnosis
of subclinical and latent HPV infection of external genital region.
Photodiagnosis Photodyn Ther. 5:251–255. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Wang XL, Wang HW, Wang HS, Xu SZ, Liao KH
and Hillemanns P: Topical 5-aminolaevulinic acid-photodynamic
therapy for the treatment of urethral condylomata acuminata. Br J
Dermatol. 151:880–885. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Forster B, Klein A, Szeimies RM and Maisch
T: Penetration enhancement of two topical 5-aminolaevulinic acid
formulations for photodynamic therapy by erbium:YAG laser ablation
of the stratum corneum: continuous versus fractional ablation. Exp
Dermatol. 19:806–812. 2010. View Article : Google Scholar
|
|
10.
|
Juzeniene A, Juzenas P and Moan J:
Application of 5-aminolevulinic acid and its derivatives for
photodynamic therapy in vitro and in vivo. Methods Mol Biol.
635:97–106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Weniger BG: New high speed jet injectors
for mass vaccination: Pros and cons of DCJIs versus MUNJIs. WHO
Initiative for Vaccine Research: Global Vaccine Research Forum;
Montreux, Switzerland: 2004
|
|
12.
|
Ross EV, Romero R, Kollias N, Crum C and
Anderson RR: Selectivity of protoporphyrin IX fluorescence for
condylomata after topical application of 5-aminolaevulinic acid:
implications for photodynamic treatment. Br J Dermatol.
137:736–742. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Loh CS, MacRobert AJ, Bedwell J, Regula J,
Krasner N and Bown SG: Oral versus intravenous administration of
5-aminolaevulinic acid for photodynamic therapy. Br J Cancer.
68:41–51. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Ayala F, Grimaldi E, Perfetto B, et al:
5-Aminolaevulinic acid and photodynamic therapy reduce HSV-1
replication in HaCat cells through an apoptosis-independent
mechanism. Photodermatol Photoimmunol Photomed. 24:237–243. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Rossi R, Bruscino N, Ricceri F, Grazzini
M, Dindelli M and Lotti T: Photodynamic treatment for viral
infections of the skin. G Ital Dermatol Venereol. 144:79–83.
2009.PubMed/NCBI
|
|
16.
|
North J, Neyndorff H, King D and Levy JG:
Viral inactivation in blood and red cell concentrates with
benzoporphyrin derivative. Blood Cells. 18:129–139; discussion.
139–140. 1992.PubMed/NCBI
|
|
17.
|
Barolet D and Boucher A: No-needle jet
intradermal aminolevulinic acid photodynamic therapy for recurrent
nodular basal cell carcinoma of the nose: a case report. J Skin
Cancer. 2011:7905092011. View Article : Google Scholar
|
|
18.
|
Sotiriou E, Apalla Z and Ioannides D:
Complete resolution of a squamous cell carcinoma of the skin using
intralesional 5-aminolevulinic acid photodynamic therapy
intralesional PDT for SCC. Photodermatol Photoimmunol Photomed.
26:269–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Cappugi P, Mavilia L, Campolmi P, Reali
EF, Mori M and Rossi R: New proposal for the treatment of nodular
basal cell carcinoma with intralesional 5-aminolevulinic acid. J
Chemother. 16:491–493. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Henta T, Itoh Y, Kobayashi M, Ninomiya Y
and Ishibashi A: Photodynamic therapy for inoperable vulval Paget’s
disease using delta-aminolaevulinic acid: successful management of
a large skin lesion. Br J Dermatol. 141:347–349. 1999.
|
|
21.
|
Ryou JH, Lee SJ, Park YM, Kim HO and Kim
HS: Acne-photodynamic therapy with intralesional injection of
5-aminolevulinic acid. Photodermatol Photoimmunol Photomed.
25:57–58. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
de Blois AW, Grouls RJ, Ackerman EW and
Wijdeven WJ: Development of a stable solution of 5-aminolaevulinic
acid for intracutaneous injection in photodynamic therapy. Lasers
Med Sci. 17:208–215. 2002.PubMed/NCBI
|
|
23.
|
Hingson RA and Hughes JG: Clinical studies
with jet injection; a new method of drug administration. Curr Res
Anesth Analg. 26:221–230. 1947. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Brearley C, Priestley A, Leighton-Scott J
and Christen M: Pharmacokinetics of recombinant human growth
hormone administered by cool.click 2, a new needle-free device,
compared with subcutaneous administration using a conventional
syringe and needle. BMC Clin Pharmacol. 7:102007. View Article : Google Scholar
|
|
25.
|
Wagner S, Dues G, Sawitzky D, Frey P and
Christ B: Assessment of the biological performance of the
needle-free injector INJEX using the isolated porcine forelimb. Br
J Dermatol. 150:455–461. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Inoue N, Kobayashi D, Kimura M, et al:
Fundamental investigation of a novel drug delivery system, a
transdermal delivery system with jet injection. Int J Pharm.
137:75–84. 1996. View Article : Google Scholar
|
